Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter ...

Aurobindo Pharma reported a 10.2% YoY decline in Q1 net profit to ₹824.2 crore, missing CNBC-TV18 estimates. Revenue rose 4%, ...

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to Rs 824 crore for the June quarter ...

One 97 Communications: Antfin in its clean out trade, to sell 5.84% stake at Rs 1020 apiece. The block deal size is Rs 3,800 ...

Aurobindo Pharma Ltd. announced on Monday an interim dividend of Rs 4 per equity share with a face value of Re 1 for the ...

Indian drugmaker Aurobindo Pharma reported a lower first-quarter profit on Monday, as expenses grew faster than revenue - stung by weak prices in the key U.S. market.

Aurobindo Pharma reports a 10% decline in consolidated net profit to Rs 824 crore for the June quarter, due to dwindling ...

Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of ₹824.20 Crore in the quarter under review, down by 10.20% on ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

Mumbai:Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...